Tech Company Financing Transactions

StroMedix Funding Round

On 4/21/2008, StroMedix received $25 million in Series B funding from New Leaf Venture Partners, Accomplice and Bessemer Venture Partners.

Transaction Overview

Company Name
StroMedix
Announced On
4/21/2008
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Series B
Investors

New Leaf Venture Partners (Lead Investor) (Ron Hunt)

Accomplice (Peter Barrett)

Bessemer Venture Partners (Christopher Gabrieli)

Frazier Healthcare Partners

Red Abbey Venture Partners

Proceeds Purpose
Earlier this year, Stromedix initiated a Phase 1 clinical trial of STX-100, the Company's lead drug candidate. STX-100 is a novel humanized monoclonal antibody licensed in 2007 from Biogen Idec, which is also a shareholder in the company.

Company Information

Company Status
Acquired or Merged
Industry
Medical Devices & Instruments
Mailing Address
One Canal Park 1120
Cambridge, MA 02141
USA
Phone
(617) 674-8400
Website
www.stromedix.com
Email Address
[email protected]
Overview
Stromedix is a clinical-stage biotechnology company committed to developing novel drugs to treat fibrotic organ failure. Stromedix will focus initially on chronic indications but plans to leverage its expertise and expand its therapeutic pipeline into related settings such as acute organ failure and cancer.
Profile
StroMedix LinkedIn Company Profile
Social Media
StroMedix Company Twitter Account
Company News
StroMedix News
Facebook
StroMedix on Facebook
YouTube
StroMedix on YouTube

Management Team

Title
Name
Email & Social
Chairman
Dan Lynch
  Dan Lynch LinkedIn Profile  Dan Lynch Twitter Account  Dan Lynch News  Dan Lynch on Facebook
Chief Executive Officer
Michael Gilman
  Michael Gilman LinkedIn Profile  Michael Gilman Twitter Account  Michael Gilman News  Michael Gilman on Facebook
Chief Medical Officer
Brad Maroni
  Brad Maroni LinkedIn Profile  Brad Maroni Twitter Account  Brad Maroni News  Brad Maroni on Facebook
VP - R & D
Shelia Violette
  Shelia Violette LinkedIn Profile  Shelia Violette Twitter Account  Shelia Violette News  Shelia Violette on Facebook

 

 

Browse more venture capital transactions:

Prev: 4/21/2008: Altor Networks venture capital transaction
Next: 4/21/2008: Travel Ad Network venture capital transaction

 

Share this article

 

News on VC Transactions

We record tech company VC transactions. All VC database entries reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.